FDA Approved: BIVALIRUDIN — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for a generic Bivalirudin product from Slate Run Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction
• Unstable Angina Pectoris

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

ORIG AP for BIVALIRUDIN (BIVALIRUDIN)